Your Basket 0

<<First <Prev    Next> Last>>
Search Results for:
Catalogue No Partner Description Species Application
HY-100013A1-10mg MedChemexpress LLC (1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] Neuroscience-Neuromodulation
HY-100013A1-25mg MedChemexpress LLC (1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] Neuroscience-Neuromodulation
HY-100013A1-5mg MedChemexpress LLC (1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] Neuroscience-Neuromodulation
HY-100013A1-50mg MedChemexpress LLC (1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] Neuroscience-Neuromodulation
HY-10126-10mg MedChemexpress LLC Barasertib-HQPA [CAS 722544-51-6] Cancer-Kinase/protease
HY-10126-100mg MedChemexpress LLC Barasertib-HQPA [CAS 722544-51-6] Cancer-Kinase/protease
HY-10126-5mg MedChemexpress LLC Barasertib-HQPA [CAS 722544-51-6] Cancer-Kinase/protease
HY-10126-50mg MedChemexpress LLC Barasertib-HQPA [CAS 722544-51-6] Cancer-Kinase/protease
HY-10127-10mg MedChemexpress LLC Barasertib [CAS 722543-31-9] Cancer-Kinase/protease
HY-10127-5mg MedChemexpress LLC Barasertib [CAS 722543-31-9] Cancer-Kinase/protease
HY-10127-50mg MedChemexpress LLC Barasertib [CAS 722543-31-9] Cancer-Kinase/protease
HY-114400-1mg MedChemexpress LLC TRPV4 agonist-1 (free base) [CAS 2314467-59-7] COVID-19-immunoregulation
HY-114400-10mg MedChemexpress LLC TRPV4 agonist-1 (free base) [CAS 2314467-59-7] COVID-19-immunoregulation
HY-114400-100mg MedChemexpress LLC TRPV4 agonist-1 (free base) [CAS 2314467-59-7] COVID-19-immunoregulation
HY-114400-25mg MedChemexpress LLC TRPV4 agonist-1 (free base) [CAS 2314467-59-7] COVID-19-immunoregulation
HY-114400-5mg MedChemexpress LLC TRPV4 agonist-1 (free base) [CAS 2314467-59-7] COVID-19-immunoregulation
HY-114400-50mg MedChemexpress LLC TRPV4 agonist-1 (free base) [CAS 2314467-59-7] COVID-19-immunoregulation
HY-114778-10mg MedChemexpress LLC Fluzoparib [CAS 1358715-18-0] Cancer-programmed cell death
HY-114778-100mg MedChemexpress LLC Fluzoparib [CAS 1358715-18-0] Cancer-programmed cell death
HY-114778-25mg MedChemexpress LLC Fluzoparib [CAS 1358715-18-0] Cancer-programmed cell death
HY-114778-5mg MedChemexpress LLC Fluzoparib [CAS 1358715-18-0] Cancer-programmed cell death
HY-114778-50mg MedChemexpress LLC Fluzoparib [CAS 1358715-18-0] Cancer-programmed cell death
HY-115510-10mg MedChemexpress LLC SPR inhibitor 3 [CAS 1292285-54-1] COVID-19-immunoregulation
HY-115510-100mg MedChemexpress LLC SPR inhibitor 3 [CAS 1292285-54-1] COVID-19-immunoregulation
HY-115510-5mg MedChemexpress LLC SPR inhibitor 3 [CAS 1292285-54-1] COVID-19-immunoregulation